We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reports Three Deaths from Squamous Cell Carcinoma in Breast Implant Capsules
FDA Reports Three Deaths from Squamous Cell Carcinoma in Breast Implant Capsules
The FDA updated its Sept. 8, 2022, safety communication to report on 19 published cases of squamous cell carcinoma (SCC) skin cancer and various lymphomas in the capsule that forms around breast implants, three of which were reported to result in patient deaths.